|
| |
CD4
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18061610 |
Vaccination-induced HBsAg-specific CD4 T cell responsed can be measured with the use of an interferon-gamma staining assay. |
| 18156204 |
there is an enrichment of both IL-17+CD4+ and CD8+ T cells in active multiple sclerosis lesions |
| 18045872 |
Detection of conformational changes within sCD4 as a result of ligand binding was followed by SAXS on sCD4 bound to two different glycoprotein ligands: the tick saliva immunosuppressor Salp15 and the HIV-1 envelope protein gp120. |
| 17543960 |
Human CD4(+)CD25(bright) T cells play a major role in tolerating conceptus antigens and therefore may contribute to the maintenance of pregnancy. |
| 17653867 |
Results suggest that Siva-1 might participate in the CD4-initiated signaling apoptotic pathway induced by the HIV-1 envelope in T-lymphoid cells. |
| 18261176 |
Campath-1H (Alemtuzumab) is an effective immunodepletion agent used in renal transplantation which increass CD4 regulatory T cells. |
| 11140838 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 15063762 |
Observational study of gene-disease association. (HuGE Navigator) |
| 15317218 |
Observational study of genotype prevalence. (HuGE Navigator) |
| 17020785 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Recent Publications on CD4: |  |
CD4(+)CD25(+) Treg induction by an HSP60-derived peptide SJMHE1 from Schistosoma japonicum is TLR2 dependent.
Chronic schistosome infection results in the suppression of host immune... | 3rd November, 2009
| Department of Pathogen Biology & Immunology, Department of Pharmacology,
| Eur J Immunol. 2009 Oct 30;39(11):3052-3065.
DOI Direct Link |
In this issue.
COVER IMAGE: This issue's cover features a composite of images showing... | 3rd November, 2009
|
| Eur J Immunol. 2009 Oct 30;39(11):2942-2943.
DOI Direct Link |
T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.
Nod2 belongs to the nucleotide-binding oligomerization domain receptor... | 3rd November, 2009
| Department of Pathology and Comprehensive Cancer Center, University of
| Nat Immunol. 2009 Nov 1.
DOI Direct Link |
Requirement for the basic helix-loop-helix transcription factor Dec2 in initial T(H)2 lineage commitment.
How naive CD4(+) T cells commit to the T helper type 2 (T(H)2) lineage is... | 3rd November, 2009
| Department of Immunology, MD Anderson Cancer Center, Houston, Texas, USA.
| Nat Immunol. 2009 Nov 1.
DOI Direct Link |
Suppressive effects of T-412, a flavone on interleukin-4 production in T cells.
Interleukin (IL)-4 has been suggested as a molecular therapeutic target to... | 3rd November, 2009
| Lab of Pathology, College of Oriental Medicine, Daejeon University,
| Biol Pharm Bull. 2009 Nov;32(11):1875-9.
|
→View more research publications. |
Press Releases on CD4:
|
 |
| Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS |
18th November, 2009 |
Sangamo BioSciences, Inc. |
RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from the University of Pennsylvania investigator sponsored Phase 1
|
| Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries |
17th November, 2009 |
Zyomyx, Inc. |
HAYWARD, Calif., Nov. 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its
|
| Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight |
5th November, 2009 |
Reportlinker |
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS |
28th October, 2009 |
Sangamo BioSciences, Inc. |
RICHMOND, Calif. Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the California Institute for Regenerative Medicine (CIRM) has
|
| Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDF's 20th World Diabetes Congress |
21st October, 2009 |
Tolerx, Inc. |
MONTREAL, Oct. 21 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies intended to treat diabetes, other autoimmune diseases and cancer by
|
CD4 results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for CD4,
or search for CD4 on BioPortfolio's antibody search engine.
This page has been viewed 454 times
Recent Search Terms used to find this page: otelixizumab pubmed | lupuzor CD4 | inverness cd4 2009 | new cd4 maps 2009 | Inverness PIMA 2009 | new HIV medical advances may 2009 | CD4 gene interactions | CD4 molecule to sale | lupuzor cd4 cd25 | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
